Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Details for Australian Patent Application No. 2006285393 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Leonard, James N.; Chu, Zhi-Liang

Agent FB Rice

Pub. Number AU-A-2006285393

PCT Pub. Number WO2007/027225

Priority 60/675,730 27.04.05 US

Filing date 26 April 2006

Wipo publication date 8 March 2007

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2007/027225 Priority application(s): WO2007/027225

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006285396-Slotted slip element for expandable packer

2006285392-Water-soluble composition and structures, and methods of making and using the same